equityflowunderstand the flow and follow it
EquityFlowCompanies › Surge

Surge

Biotech · Paris, FR

High-dimensional immune-system analysis for precision medicine.

Funding history

DateRoundAmount
Mar 2024Funding round
Surge, a Paris immune-system-analysis biotech, raised EUR7.5M led by Eurazeo.
$8.1M

Investors

Tap an investor to see what else they have backed.

Other companies in Biotech

Other companies in FR

Other companies at Unknown stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.